Anne-Katrin Orlovius

Anne-Katrin Orlovius is a highly experienced professional in pharmaceutical and analytical development, with a career spanning various prominent positions in the industry. At Elanco, from May 2021 to June 2022, leadership roles included Head of Analytical Development & QC and Head of Pharmaceutical Development Unit. Prior experience at Bayer Animal Health from April 2015 to August 2020 involved roles such as Laboratory Manager Analytics in Pharmaceutical Development. Earlier positions include Wissenschaftlicher Mitarbeiter at Institut für Biochemie Deutsche Sporthochschule Köln and Apothekerin at Apotheke Zum Goldenen Horn. Anne-Katrin Orlovius holds a Dr. rer. nat. in Pharmazie and a Diplom in Aufbaustudiengang Diplom-Pharmazie, both from The University of Bonn.